Skip to main content
Premium Trial:

Request an Annual Quote

NCI Using Tranche Network to Disseminate Mouse Proteomics Data

NEW YORK (GenomeWeb News) – The National Cancer Institute will release proteomic data from its Mouse Proteomic Technologies Initiative (MPTI) to the public on the file sharing network and data warehouse Tranche, the project announced this week.
 
The MPTI collects tissue and serum measurements from mouse models of different types of cancers using analytical techniques such as mass spectrometry. Tranche researchers, along with University of Michigan researcher Philip Andrews, deposited nearly 1 terabyte of MPTI raw data into the Tranche network, where it can be shared between participating researchers.
 
The dataset is now being released in publicly accessible formats as well and is available to others in the research community. Because of the encryption used on the site, data on Tranche can be privately used by labs with access to the information until it is ready to be released to the public.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.